Companies / EW vs STE
EW vs STE: Edwards Lifesciences and STERIS
Edwards Lifesciences (EW) reported $6.1B in revenue against a 17.7% net margin, while STERIS (STE) reported $5.9B at a 13.2% net margin, most recently.
| Metric | EW | STE |
|---|---|---|
| Revenue | $6.1B | $5.9B |
| Net Income | $1.1B | $0.8B |
| Gross Margin | 78.0% | 44.2% |
| Operating Margin | 20.8% | 18.6% |
| EPS (Diluted) | $1.83 | $7.93 |
| Free Cash Flow | $1.3B | $1.0B |
| Total Debt | $0.6B | $1.9B |
| P/E Ratio | 46.6× | 27.9× |
| P/B Ratio | 4.8× | 3.0× |
| Stock Price | $100.81 | $254.27 |
Free: last 5 years
| Fiscal year | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| EW Revenue | ••••• | ••••• | ••••• | ••••• | $5.2B | $4.5B | $5.0B | $5.4B | $6.1B |
| STE Revenue | ••••• | ••••• | ••••• | ••••• | — | $4.2B | $4.5B | $5.1B | $5.5B |